Implications of Radiotherapy Utilization in Korea from 2010 to 2019
10.3346/jkms.2021.36.e117
- Author:
Jeongshim LEE
1
;
Woo Chul KIM
;
Won Sup YOON
;
Chai Hong RIM
Author Information
1. Department of Radiation Oncology, Inha University Hospital, Inha University College of Medicine, Incheon, Korea
- Publication Type:Original Article
- From:Journal of Korean Medical Science
2021;36(18):e117-
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:This study was to assess the rate of radiotherapy (RT) utilization according to the modality in South Korea to identify the implications of contemporary RT patterns.
Methods:We collected information from claims and reimbursement records of the National Health Insurance Service from 2010 to 2019. We classified the location of each institution as capital (Seoul, Incheon, and Gyeonggi-do) and non-capital areas.
Results:The rate of RT utilization in total cancer patients nationwide was 24.5% in 2010, which consistently has increased to 36.1% in 2019 (annual increase estimate [AIE], 4.5%). There was an abrupt increase in patients receiving intensity-modulated RT (IMRT), with an AIE of 33.5%, and a steady decline in patients receiving three-dimensional conformal RT (3DCRT), with an AIE of −7.1%. The commonest RT modality was IMRT (44.5%), followed by 3DCRT and stereotactic RT (SRT) (37.2% and 13.5%) in 2019. An increasing trend of advanced RT (such as IMRT and SRT) utilization was observed regardless of the region, although the AIE in the capital areas was slightly higher than that in non-capital areas.
Conclusion:The utilization of overall RT application and especially of advanced modalities remarkably increased from 2010 to 2019. We also found gaps in their AIEs between capital and non-capital areas. We should ensure that advanced RT is accessible to all cancer patients across South Korea.
